Immuno-Oncology Market Poised for Substantial Growth, Driven by Advanced Technologies and Biomarker Integration
January 31, 2024 08:10 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Immuno-oncology Clinical Trials Market Poised for Remarkable Growth, with USD 12.87 Billion Forecasted by 2030
January 24, 2024 08:54 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Immuno-oncology Clinical Trials Market by Design (Expanded Access Trials, Interventional Trials, Observational Trials), Phase (Phase I, Phase...
Solid Tumor Cancer Treatment Market Anticipates Robust Growth as Innovations and Global Health Challenges Emerge
January 23, 2024 02:53 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Solid Tumor Cancer Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The latest research publication...
Immunotherapy Advancements: CD40 Agonist and Antagonist Research Fuels Oncology and Autoimmunity Treatment Innovations
December 14, 2023 05:33 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "CD40 Agonists & CD40/L Antagonists Pipeline Review" report has been added to ResearchAndMarkets.com's offering. The global scientific community...
Global Claudin 18.2-Targeted Immunotherapy Landscape Analysis Report 2023: Detailed Profiles of 56 Anti-CLDN18.2 Immunotherapy Candidates
September 22, 2023 04:23 ET
|
Research and Markets
Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry...
Global Oligonucleotide Therapy Markets 2023-2027: Driving Precision Medicine for Targeted Treatment
July 28, 2023 05:33 ET
|
Research and Markets
Dublin, July 28, 2023 (GLOBE NEWSWIRE) -- The "Oligonucleotide Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global oligonucleotide therapy...
Advances in Cancer Immunotherapy: Breakthrough Techniques and Key Players Explored in New Report
July 21, 2023 04:53 ET
|
Research and Markets
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Markets. The Race for the Cures. Market Forecasts for Immuno-Oncology Therapeutics by Therapy, by Cancer and by Customer including...
Global Immuno-Oncology Thematic Intelligence Report 2023: Focus on Trends in Bispecific Antibodies, Cancer Vaccines, Cell Therapies, Checkpoint Modulators, Cytokines, & Oncolytic Viruses
June 13, 2023 04:48 ET
|
Research and Markets
Dublin, June 13, 2023 (GLOBE NEWSWIRE) -- The "Immuno-Oncology - Thematic Intelligence" report has been added to ResearchAndMarkets.com's offering.This report includes coverage of immuno-oncology...
Cancer Immunotherapy Market to reach USD 261.7 Bn in 2031, expanding at a CAGR of 13.6%: TMR Report
May 11, 2023 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 11, 2023 (GLOBE NEWSWIRE) -- The global cancer immunotherapy market is projected to flourish at a CAGR of 13.6% from 2022 to 2031. As per the report...
Immuno-Oncology (IO) Market is Expected to Reach the Valuation of USD 156.05 Billion by 2030, Size, Share, Growth, Trends, Demand and Opportunity Analysis
April 27, 2023 03:43 ET
|
Data Bridge Market Research
MELBOURNE, April 27, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research has unveiled a new report called "Immuno-Oncology (IO) Market" which provides an in-depth exploration of growth strategies,...